Skip to content

Effect of Rosmarinus ointment on phlebitis

Effect of topical using Rosmarinus ointment on the incidence and severity of phlebitis due to antibiotic therapy in Intensive Care Units

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016021914930N5
Enrollment
46
Registered
2016-05-21
Start date
2016-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

phlebitis. Other disorders of circulatory system in diseases classified elsewhere

Interventions

Intervention 1: 2/8 gr of Rosmarinus ointment for topical using, every 12 hours, two times a day, from the first day of antibiotic therapy up to the third day. Intervention 2: 2/8 gr of Oserin ointme
Prevention
2/8 gr of Rosmarinus ointment for topical using, every 12 hours, two times a day, from the first day of antibiotic therapy up to the third day
2/8 gr of Oserin ointment for topical using, every 12 hours, two times a day, from the first day of antibiotic therapy up to the third day

Sponsors

Vice chancellor for Research of Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:18-60 years ; antibiotic therapy management with Cefteriaxon and Vancomycin; Application No. 20-18 catheter Supa Company; catheterization into arm vein; No septic conditions during catheterization. Exclusion criteria: underlying fever and neutropenia;received another Vegetable oil or drug; no sing of allergy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Phlebitis incidence. Timepoint: 24,48,72. Method of measurement: phlebitis numerical scale.

Secondary

MeasureTime frame
Phlebitis severity. Timepoint: 24,48,72. Method of measurement: phlebitis numberical scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarziyeh Asadi Zaker

Ahvaz Jundishapur University of Medical Sciences

maraiehasdizaker@yahoo.com+98 613738622

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026